Goldman Sachs’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-37,400
| Closed | -$1.47M | – | 6069 |
|
|
2023
Q2 | $1.47M | Buy |
+37,400
| New | +$1.32M | ﹤0.01% | 4084 |
|
|
2022
Q4 | – | Sell |
-75,000
| Closed | -$1.35M | – | 6397 |
|
|
2022
Q3 | $1.35M | Buy |
+75,000
| New | +$984K | ﹤0.01% | 4317 |
|
|
2017
Q1 | – | Sell |
-195,400
| Closed | -$944K | – | 7073 |
|
|
2016
Q4 | $944K | Buy |
195,400
+112,600
| +136% | +$3.34M | ﹤0.01% | 4509 |
|
|
2016
Q3 | $3.82M | Buy |
82,800
+50,300
| +155% | +$2.84M | ﹤0.01% | 3275 |
|
|
2016
Q2 | $1.66M | Sell |
32,500
-45,300
| -58% | -$2.25M | ﹤0.01% | 3768 |
|
|
2016
Q1 | $3.29M | Buy |
77,800
+27,800
| +56% | +$1.42M | ﹤0.01% | 3056 |
|
|
2015
Q4 | $3.93M | Hold |
50,000
| – | – | ﹤0.01% | 3057 |
|
|
2015
Q3 | $2.03M | Buy |
+50,000
| New | +$2.65M | ﹤0.01% | 3784 |
|